Nasdaq 100 Stocks SEC Filings — May 11, 2026

11-05-2026

Faraday Future announced leadership changes effective May 5, 2026, with founder YT Jia appointed as sole Global CEO, Jerry Wang as Global Executive Chairman, Matthias Aydt resigning as Global Co-CEO to become an advisor, and Chad Chen as Lead Independent Director. The company highlights the return of its founding team to drive the Dual-Engine Strategy of EAI Robotics + EAI EV, with 68 EAI robots shipped as of April 30, 2026, achieving positive gross margins and targeting 200 units by end of June and over 1,000 cumulatively in 2026. Plans include announcing upgraded five transformation initiatives next week to accelerate growth as a Physical AI company.

• · SEC investigation concluded with no penalties.
• · FF in 180-day period to regain Nasdaq compliance.
• · Matthias Aydt to continue as internal advisor while new role discussed.

11-05-2026

Hapi Metaverse Inc. reported Q1 2026 revenue of $60,902, up 10% YoY from $55,301, driven by Food & Beverage growth, with gross profit rising 38% to $38,981 and net loss narrowing significantly to $(246,374) from $(1,543,464) due to lower operating expenses and absence of prior year's large unrealized loss. However, cash and cash equivalents declined QoQ to $418,841 from $497,189 amid $320,248 operating cash burn, total assets fell 3% to $1,540,389, and stockholders' deficit worsened slightly to $(1,731,469). The company remains heavily reliant on related party financing and notes, with ongoing net losses.

• · Operating cash burn improved 8.5% YoY to $320,248 from $350,195, supported by $183,508 advances from related parties.
• · Related party liabilities transferred to equity: $162,482.
• · Foreign currency translation adjustment contributed $63,331 to other comprehensive income.

11-05-2026

MUFG Bank, Ltd. filed a Form 13F-HR on May 11, 2026, reporting its institutional investment holdings as of March 31, 2026, as the parent company of several investment manager subsidiaries including WealthNavi Inc., MUFG Securities Americas Inc., and others. The filing discloses a portfolio with key positions such as $523,063,146 in Grab Holdings Limited Class A Ordinary Shares (142,913,428 shares), $2,307,899,802 in US Bancorp Del Common Stock (44,374,155 shares), $8,860,722 in CME Group Inc Common Stock (30,001 shares), $118,817,118 in SPDR S&P 500 ETF Trust Units (182,700 shares), and $80,956,563 in Polestar Automotive Holding UK Sponsored ADS (4,395,036 shares). No period-over-period comparisons or performance metrics are provided in the filing.

• · Filing is a 13F combination report covering subsidiaries' managed accounts where MUFG Bank does not directly exercise investment discretion.
• · Report period end: March 31, 2026; Filed as of date: May 11, 2026.
• · MUFG Bank, Ltd. EIN: 135611741; State of Incorporation: M0 (likely Missouri proxy for non-US).

11-05-2026

Elme Communities reports net assets in liquidation of $203,909 thousand as of March 31, 2026, down 14.6% from $238,915 thousand at December 31, 2025, amid ongoing liquidation with total assets declining 72.3% to $585,231 thousand and income producing property dropping 29.9% to $544,250 thousand; however, debt payable was reduced 35.1% to $337,492 thousand. Cash, cash equivalents, and restricted cash fell sharply 97.1% to $39,273 thousand, following the payout of a $1,303,723 thousand liquidating distribution. On a going concern basis for the three months ended March 31, 2025, the company recorded real estate rental revenue of $61,493 thousand but a net loss of $4,675 thousand.

• · Dividends declared $0.18 per common share for three months ended March 31, 2025
• · Net cash provided by operating activities $16,175 thousand for three months ended March 31, 2025
• · Net cash used in investing activities $5,698 thousand for three months ended March 31, 2025
• · Basic and diluted net loss per common share $(0.05) for three months ended March 31, 2025
• · Cash paid for interest $11,982 thousand for three months ended March 31, 2025

11-05-2026

MoonLake Immunotherapeutics announced a positive final pre-BLA meeting with the FDA on April 1, 2026, aligning on BLA submission plans for sonelokimab in hidradenitis suppurativa (HS) by end-September 2026, supported by strong MIRA trial data (~43% HiSCR75 response and ~29 percentage point delta-to-placebo). The company ended Q1 2026 with $357.9 million in cash, cash equivalents, and short-term marketable debt securities, providing a runway to end-2027, plus up to $400 million available via debt facility with Hercules Capital. However, G&A expenses increased to $15.5 million in Q1 2026 from $9.2 million in Q4 2025 (up $6.3 million due to stock option cancellations), while R&D expenses were relatively flat at $54.5 million versus $56.0 million.

• · BLA acceptance expected by end-November 2026, with potential Priority Review due to adolescent data inclusion
• · Upcoming milestones: Q2 2026 52-week VELA-1/2 data; mid-2026 IZAR-1 and VELA-TEEN primary endpoints; Q4 2026 IZAR-2 primary endpoint
• · Potential first U.S. commercial launch in H2 2027 subject to FDA approval
• · VELA-2 week 16 primary endpoint did not achieve statistical significance (p=0.053) due to intercurrent events in placebo arm

11-05-2026

Atmus Filtration Technologies Inc. (NYSE: ATMU) announced the appointment of Kevin Carpenter as Senior Vice President and Chief Supply Chain Officer, effective immediately on May 11, 2026. Carpenter, with over 25 years of experience from The Toro Company, Carrier Global Corporation, and Rockwell Automation, Inc., will oversee procurement, manufacturing, health, safety, environment, transportation, and logistics. The company, headquartered in Nashville, Tenn., employs nearly 5,000 people worldwide across its Power Solutions (Fleetguard®) and Industrial Solutions (Koch Filter®) segments.

• · Kevin Carpenter holds a BS in Electrical Engineering from Georgia Institute of Technology, BS in General Engineering from Morehouse College, MBA from Weatherhead School of Management at Case Western Reserve University, and MS in Industrial Engineering from Youngstown State University.

11-05-2026

Intellia Therapeutics reported positive Phase 3 HAELO topline data for lonvo-z in HAE, achieving 87% reduction in attacks (0.26 vs 2.10 monthly rate) and 62% attack-free rate vs 11% placebo, and initiated rolling BLA submission targeting U.S. launch in H1 2027. The company resumed patient screening in MAGNITUDE and MAGNITUDE-2 Phase 3 trials for nex-z in ATTR after FDA clinical hold lift, with cash of $517.2M as of Q1 end plus $207M from April offering expected to fund operations into 2028. Q1 collaboration revenue fell 9.5% YoY to $15.0M, R&D expenses dropped 25.5% to $80.7M, but G&A rose 20.1% to $34.8M, narrowing net loss to $96.2M from $114.3M YoY.

• · All TEAEs in lonvo-z arm were mild or moderate (Grade 1 or 2) with no serious adverse events as of February 10, 2026 data cutoff.
• · Plans to complete BLA submission in H2 2026; patient enrollment completion in MAGNITUDE-2 in H2 2026.
• · Upcoming events: Bank of America Securities Health Care Conference (May 12, 2026), RBC Capital Markets Global Healthcare Conference (May 20, 2026), Jefferies Global Healthcare Conference (June 3, 2026), EAACI Congress (June 12-15, 2026).

11-05-2026

NLB Skladi, upravljanje premozenja, d.o.o. disclosed U.S. equity holdings totaling $2085748492 across 335 positions as of March 31, 2026, in its 13F-HR filing submitted May 11, 2026. Top holdings by value include Apple Inc. COM at $104838111 (413090 shares), Alphabet Inc. CAP STK CL A at $97744232 (339909 shares), Amazon.com Inc. COM at $74913261 (359693 shares), and Broadcom Inc. COM at $70580041 (228038 shares), with all positions held solely. No prior period data provided for comparison; all reported with sole voting and investment discretion.

• · Report period end date: 03/31/2026
• · Filing date: 05/11/2026
• · Signed date: 04/22/2026
• · Filer location: Tivolska cesta 48, Ljubljana, 1000, Slovenia
• · All 335 holdings reported as SH SOLE (sole voting and discretion power); no shared power, puts, or calls indicated

11-05-2026

Adial Pharmaceuticals reported Q1 2026 financial results with cash and equivalents at $4.6M as of March 31, 2026 (down from $5.9M at December 31, 2025), R&D expenses decreased 42% YoY to $0.4M, G&A expenses increased 3% YoY to $1.6M, and net loss improved to $2.0M from $2.2M YoY. The company provided a positive business update on regulatory tailwinds including potential FDA flexibility for single pivotal trials, bipartisan support for non-abstinence AUD endpoints, a collaboration framework with Molteni Farmaceutici for European commercialization, and IP protection for AD04 extending to at least 2045. However, cash is projected to fund operations only into the second half of 2026, with active pursuit of financing or strategic alternatives needed for Phase 3 advancement.

• · Cash runway projected into second half of 2026 based on current plans
• · International patent application for AD04, if granted, extends protection through at least 2045

11-05-2026

MUFG Securities Americas Inc. filed its 13F-HR on May 11, 2026, disclosing institutional holdings as of March 31, 2026, primarily in over 250 U.S. equities with no changes reported across all positions (all show 0 added or sold shares). Top holdings include Apple Inc. (406150 shares), Amazon.com Inc. (270251 shares), Alphabet Inc. Class A (161064 shares) and Class C (129379 shares), and Broadcom Inc. (131166 shares). The portfolio also features fixed income positions such as $2000000 in PPL Capital Funding Inc. notes and $3000000 in Pinnacle West Capital Corp. Class E, with overall holdings unchanged quarter-over-quarter.

• · Report period end: March 31, 2026
• · Filing CIK: 0000867626
• · Business address: 1221 Avenue of the Americas, 6th Floor, New York, NY 10020-1001
• · All positions report 0 changes in shares held

11-05-2026

MUFG Securities (Canada), Ltd. filed a 13F-HR disclosing 43 equity positions totaling $3,477,444,816 as of March 31, 2026, with no reported changes in share counts. Top holdings include Shopify Inc Class A ($215,401,840; 1,818,588 shares), Toronto Dominion Bank ($232,093,863; 2,489,513 shares), and Royal Bank of Canada ($334,556,497; 2,073,220 shares). The portfolio is heavily weighted toward Canadian financials, energy, and mining companies.

• · Filing submitted on May 11, 2026, for period ending March 31, 2026.
• · All reported holdings show 0 changes in shares (no additions or reductions).
• · Filer CIK: 0001656187; SEC file number: 028-21099.

11-05-2026

Nomura Asset Management Co Ltd filed its 13F-HR on May 11, 2026, reporting U.S. equity holdings as of March 31, 2026, across five affiliates including NAM Tokyo, Malaysia, U.K., Europe, and Taiwan. Top positions include Apple Inc. valued at $1,515,303,953 (5,970,700 shares), Alphabet Inc. Class A at $856,641,240 (2,979,000 shares), and Amazon.com Inc. at $845,075,935 (4,057,598 shares). For certain positions, voting authority exceeds investment discretion due to sub-advisers.

• · Business address: Toyosu Bayside Cross Tower, 2-2-1, Toyosu, Koto-ku, Tokyo 135-0061.
• · SEC file number: 028-06746.
• · Certain positions delegate investment discretion to sub-advisers while retaining voting authority.

11-05-2026

Sequans Communications reported total revenue of $26,325 thousand for the year ended December 31, 2025, down 29% from $36,831 thousand in 2024, with product revenue increasing 29% to $15,489 thousand while license, royalty, and services revenue declined 59% to $10,262 thousand. Gross profit fell 49% to $14,112 thousand, and the company recorded an operating loss of $111,892 thousand compared to operating income of $69,533 thousand in 2024, driven by new digital asset impairment losses of $67,375 thousand and losses on sales of $6,102 thousand. Net loss was $109,279 thousand versus a profit of $57,567 thousand in 2024.

• · Customer C revenue share declined from 56% in 2023 to less than 10% in 2025.
• · US revenue decreased to $9,248 thousand (35% of total) from $20,368 thousand (55%) YoY.
• · Bitcoin acquisitions: 3,233.8038 units for $377,200 thousand; disposals: 1,095.0001 units.
• · No single customer exceeded 33% of trade receivables at December 31, 2025.

11-05-2026

MUFG Securities EMEA plc filed its 13F-HR on May 11, 2026, reporting $6,702,737,093 in total investments across 551 positions as of March 31, 2026. Top holdings include Apple Inc ($319444204 value, 1258695 shares), Broadcom Inc ($308391121 value, 996385 shares), Alphabet Inc CAP STK CL A ($243018394 value, 845105 shares), and Alphabet Inc CAP STK CL C ($107919314 value, 376209 shares). The filing shows sole investment discretion (1,2) and voting authority for all positions with no shared or other voting authority indicated.

• · SEC file number: 028-15731
• · Central Index Key: 0001597694
• · Business address: Ropemaker Place, 25 Ropemaker Street, London X0 EC2Y 9AJ
• · Former name: Mitsubishi UFJ Securities International PLC (changed 20140121)

11-05-2026

Camden National Corporation announced that William H. Martel, its Executive Vice President and Chief Technology Officer, provided notice on May 6, 2026, of his intention to retire effective July 31, 2026. The Form 8-K was filed on May 11, 2026, under Items 5.02 and 9.01, with no additional financial or compensatory details disclosed.

• · Securities registered: Common Stock, without par value (CAC) on The NASDAQ Stock Market LLC

11-05-2026

Strengthening Families & Communities, LLC filed its 13F-HR on May 11, 2026, disclosing total portfolio holdings valued at $400,818,882 as of March 31, 2026, across 589 positions primarily in equities and ETFs. Top holdings include Apple Inc. ($14,054,378), Tidal Trust I SP Funds S&P 500 Sharia ($12,828,767), and NVIDIA Corp ($12,521,519), with a notable emphasis on technology stocks and Sharia-compliant funds. No prior period data is provided in the filing for comparison.

• · All reported holdings have sole voting and investment discretion (SH SOLE)
• · No put or call options reported (0 0 across positions)
• · Portfolio includes Sharia-compliant ETFs such as WAHED DOW JONES ISLAMIC WORLD and LISTED FDS TR WAHED FTSE USA SHARIAH ETF
• · Filer CIK: 0001921196, SEC file number: 028-22399

11-05-2026

Cadinha & Co LLC filed its quarterly 13F-HR on May 11, 2026, reporting total equity holdings of $536,782,504 across 103 positions as of March 31, 2026. Top holdings by value include iShares Gold Trust ($45,985,314), Berkshire Hathaway Inc Cl B ($36,255,314), Alphabet Inc Cl A ($29,554,088), NVIDIA Corp ($25,221,931), and Microsoft Corp ($16,193,073), reflecting exposure to technology, gold, and diversified equities. No period-over-period changes are disclosed in this filing.

• · Filer CIK: 0000923469
• · SEC File Number: 028-04292
• · Business address: 900 Fort Street Mall, Suite 1450, Honolulu, HI 96813
• · Business phone: 8085239488
• · Conformed period end: March 31, 2026

11-05-2026

Apple Hospitality REIT, Inc. filed an 8-K on May 11, 2026, under Items 7.01 and 9.01, announcing the availability of an updated investor presentation on its website. The presentation contains operating statistics for April and May 2026 and will be used at various conferences and meetings in the coming weeks. Exhibit 99.1 provides the investor presentation dated May 11, 2026.

• · Presentation furnished as Exhibit 99.1, not deemed 'filed' under Section 18 of the Exchange Act.
• · Securities: Common Shares, no par value (APLE) on The New York Stock Exchange.

11-05-2026

Metagenomi, Inc. reported collaboration revenue of $1,248 thousand for Q1 2026, a 70% YoY decline from $4,127 thousand, while research and development expenses fell 23% to $19,300 thousand and general and administrative expenses decreased 4% to $6,535 thousand, leading to total operating expenses of $25,835 thousand and a narrower net loss of $23,059 thousand versus $25,039 thousand in Q1 2025. Cash and cash equivalents decreased to $25,306 thousand as of March 31, 2026 from $41,722 thousand at December 31, 2025, with net cash used in operating activities improving to $21,175 thousand from $22,842 thousand YoY. Total assets stood at $196,953 thousand, down 11% QoQ, reflecting ongoing cash burn despite cost controls.

• · Net loss per share: $(0.61) basic and diluted for Q1 2026 versus $(0.68) for Q1 2025.
• · Stock-based compensation expense: $2,552 thousand in Q1 2026.
• · Cash, cash equivalents, and restricted cash: $29,699 thousand as of March 31, 2026.

11-05-2026

Radiant Logistics reported Q3 FY26 revenues of $214.1 million, flat at less than 0.1% YoY from $214.0 million, while gross profit declined 1.1% to $53.9 million and adjusted EBITDA fell 17.0% to $7.8 million; however, net income rose to $4.7 million or $0.10 per share from $2.5 million or $0.05 per share. For the nine months ended March 31, 2026, revenues decreased to $672.9 million from $682.1 million, with adjusted EBITDA down to $26.3 million from $30.9 million. The company repurchased 585,050 shares for $3.5 million and highlighted progress on Navegate platform and 'Ray' AI agent amid a challenging freight environment.

• · Q3 FY26 adjusted net income of $5.3 million or $0.11 per share, down from $6.9 million or $0.15/$0.14 per share in Q3 FY25.
• · 9M FY26 adjusted net income of $17.9 million or $0.38/$0.37 per share, normalizing to $19.2 million excluding $1.3 million First Brands adjustment.
• · Share repurchases at average cost of $5.97 per share.
• · Earnings call scheduled for May 11, 2026 at 4:30 PM Eastern.

11-05-2026

On May 11, 2026, Alphabet Inc. closed concurrent underwritten public offerings of €9 billion aggregate principal amount of euro-denominated senior notes and C$9.5 billion aggregate principal amount of Canadian dollar-denominated senior notes. The Euro Notes comprise six tranches with maturities from 2030 to 2063 and coupon rates ranging from 3.200% to 4.800%. The Canadian Notes include four tranches maturing from 2031 to 2056 with coupon rates from 3.650% to 5.000%.

• · Notes issued pursuant to Indenture dated February 12, 2016.
• · Registration statement on Form S-3 (File No. 333-286752).

11-05-2026

Murphy USA Inc. filed a Certificate of Amendment to its Restated Certificate of Incorporation, amending Article 6 to de-stagger its Board of Directors (currently 10 members) with elections transitioning to annual terms starting at the 2029 annual meeting, eliminating cumulative voting, allowing the board to fill vacancies, and changing director removal to with or without cause post-2029. Article 7 was amended to specify stockholder meeting procedures and prohibit actions by written consent. The amendment was certified by Gregory L. Smith on May 7, 2026, and filed on May 11, 2026.

• · Amendments adopted in accordance with Section 242 of the Delaware General Corporation Law.
• · Quorum for Board meetings is a majority of the Whole Board.
• · Prior to 2029, directors removable only for cause by majority vote of outstanding voting securities; after 2029, with or without cause.

11-05-2026

Booking Holdings Inc. issued €1,900,000,000 aggregate principal amount of senior notes in a registered public offering, comprising €600,000,000 of 3.500% Senior Notes due 2030, €700,000,000 of 4.000% Senior Notes due 2034, and €600,000,000 of 4.500% Senior Notes due 2039. The issuance followed an underwriting agreement dated May 5, 2026, with officers' certificates executed on May 11, 2026, under the 2017 Base Indenture. Interest on all notes accrues at their respective rates, payable annually starting May 11, 2027, with optional redemption provisions prior to par call dates.

• · Notes are general senior unsecured obligations ranking equally with other senior unsecured debt.
• · Redemption prior to par call dates (one month for 2030 Notes, three months for 2034/2039 Notes) at make-whole price plus accrued interest; at par thereafter.
• · Agency Agreement appoints U.S. Bank Europe DAC, UK Branch as paying agent and U.S. Bank Trust Company, National Association as transfer agent.

11-05-2026

AParadise Acquisition Corp. filed an S-1 registration statement on May 11, 2026, disclosing its financial position as of March 31, 2026, and comparative data for the three months ended March 31, 2026 and 2025, including details on redeemable and non-redeemable Class A and Class B ordinary shares. The filing references prior IPO activities on July 31, 2025, sponsor private placements, founder shares, and over-allotment options exercised on September 15, 2025, with no operational revenues typical for a SPAC but ongoing trust-related balances. No material period-over-period changes are quantifiable from the provided XBRL tags, indicating stable pre-business combination status.

• · Company incorporation date: November 9, 2022.
• · IPO date: July 31, 2025.
• · Over-allotment option date: September 15, 2025.
• · Business combination related activity noted on November 26, 2025 (e.g., BVIAcquirorUnits).

11-05-2026

Evolution Metals & Technologies Corp. (EM&T) has secured a flexible, multi-tranche convertible facility of up to $100 million from Yorkville Advisors Global, LP to fund expansion of commercial operations, including increased production of high-performance rare earth magnets and development of a U.S. industrial campus. David Wilcox, Executive Chairman, highlighted the investment's role in advancing U.S. critical materials production ex-China. Clear Street LLC served as sole advisor and placement agent.

• · Investment structured as debentures convertible into common stock, subject to Nasdaq rules and including registration rights.
• · EM&T focused on non-China dependent supply chain from end-of-life electronics, batteries, and concentrates to finished magnets.
• · Filing date: May 11, 2026

11-05-2026

The Municipal Employees' Retirement System of Michigan filed its 13F-HR on May 11, 2026, reporting 29 holdings totaling $8,223,951,000 as of March 31, 2026. Top positions include the Invesco S&P 500 QVM Multifactor ETF at $1,306,065,000, SPDR Portfolio Intermediate Term Treasury ETF at $1,109,213,000, and iShares Core S&P 500 ETF at $1,069,920,000, with all holdings held with sole voting authority. The portfolio features a mix of equity ETFs, bond ETFs, and treasury ETFs, reflecting broad market and fixed income exposure.

• · Report period end date: 03/31/2026
• · Filing as of date: 05/11/2026
• · All reported holdings have sole shared responsibility voting authority
• · Portfolio domiciled at 1134 Municipal Way, Lansing, MI 48917

11-05-2026

Verizon Communications Inc. filed a Form 8-K on May 11, 2026, under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits), attaching a press release dated May 11, 2026 as Exhibit 99.1. The filing lists numerous outstanding notes with various coupon rates and maturities traded on the New York Stock Exchange and Nasdaq Global Select Market, including common stock (par value $0.10). No financial metrics, period-over-period comparisons, or performance changes were disclosed in the filing body.

• · Filing Type: 8-K, Items 8.01 and 9.01
• · Date of Report: May 11, 2026
• · Securities registered: Common Stock (VZ) on NYSE and Nasdaq; multiple notes e.g., 1.375% Notes due 2026 (VZ 26B), 0.875% Notes due 2027 (VZ 27E), up to 5.7427% Fixed-to-Fixed Rate Junior Subordinated Notes due 2056 (VZ 56C)

11-05-2026

Intellicheck, Inc. held its virtual Annual Stockholders Meeting on May 7, 2026, where shareholders elected Dondi Black, Gregory Braca, Dylan Glenn, Bryan Lewis, Guy L. Smith, and David E. Ullman as directors for one-year terms. Stockholders also ratified Forvis Mazars, LLP as the independent auditors for the fiscal year ending December 31, 2026, approved an advisory vote on named executive officer compensation, and selected annual frequency for future advisory votes on executive compensation. All proposals passed with strong majorities and minimal opposition or abstentions.

• · Broker non-votes totaled 3,770,688 across director elections, executive compensation advisory vote, and frequency vote.
• · Auditor ratification had 15,117,990 votes for, 20,735 against, and 52,913 abstentions.
• · Executive compensation advisory vote: 11,132,336 for, 237,429 against, 51,185 abstain.
• · Frequency vote: 9,341,545 for one year, 1,634,014 for three years, 415,279 for two years, 30,112 abstain.

11-05-2026

MetaVia Inc. issued a press release announcing the acceptance of a late-breaking abstract on DA-1726, a novel dual oxyntomodulin analog targeting GLP-1 and glucagon receptors for obesity treatment, for poster presentation at the EASL Congress 2026 in Barcelona, Spain, from May 27–30, 2026. The disclosure is furnished under Item 7.01 and not deemed filed under the Exchange Act.

• · DA-1726 targets both GLP-1 (GLP1R) and glucagon (GCGR) receptors
• · Press release attached as Exhibit 99.1

11-05-2026

Elo Mutual Pension Insurance Co filed its 13F-HR on May 11, 2026, reporting holdings as of March 31, 2026, with a total portfolio value of $6,064,829,293 across 581 positions, all held solely. Top holdings by value include Apple Inc. ($401,858,192, 1,583,428 shares), Alphabet Inc. Class A ($182,723,675, 635,428 shares), Meta Platforms Inc. Class A ($160,872,086, 281,181 shares), Alphabet Inc. Class C ($153,330,972, 534,515 shares), and iShares Broad USD High Yield Corporate Bond ETF ($137,965,800, 3,745,000 shares). No period-over-period changes are disclosed in this filing.

• · Filing submitted from Espoo, Finland (H9)
• · All positions reported as sole discretionary holdings (SH SOLE)

11-05-2026

Mueller Industries Inc. held its Annual Meeting of Stockholders on May 7, 2026, electing all director nominees (with For votes ranging from 87.4M to 92.8M shares and withheld votes up to 6.5M for Terry Hermanson), ratifying Ernst & Young LLP as auditors for the fiscal year ending December 26, 2026 (98.5M For), and approving executive compensation on an advisory basis (87.6M For vs. 4.3M Against). On May 8, 2026, the Board declared a regular quarterly cash dividend of $0.35 per share, payable June 19, 2026 to shareholders of record on June 5, 2026. All proposals passed with majority support despite some notable withheld votes on certain directors.

• · Fiscal year for auditors ends December 26, 2026
• · Common stock: $0.01 par value, traded on NYSE under symbol MLI

11-05-2026

Tarsadia Capital, LLC, a Delaware-incorporated investment firm based in New York, NY, filed its Form 13F-HR on May 11, 2026, reporting holdings as of March 31, 2026. The information table indicates no reportable positions (empty table with zero values for shares and other metrics). This filing discloses no changes or activity in managed securities.

• · SEC File Number: 028-20077
• · Business Phone: (332) 225-8207
• · Fiscal Year End: December 31
• · Central Index Key: 0001777371